Factor IX activity measurement of recombinant FIX Fc fusion protein eftrenonacog alfa with one-stage clotting and chromogenic substrate assay

被引:0
|
作者
Prudkova, Marie [1 ,2 ,3 ,4 ]
Chytra, Dagmar [1 ,4 ]
Smejkal, Petr [1 ,4 ]
Zavrelova, Jirina [1 ,4 ]
Kovarikova, Jana [1 ,4 ]
Penka, Miroslav [1 ,2 ,3 ]
Bulikova, Alena [1 ,2 ,3 ]
机构
[1] Univ Hosp Brno, Dept Clin Hematol, Brno, Czech Republic
[2] Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[3] Masaryk Univ Brno, Fac Med, Brno, Czech Republic
[4] Masaryk Univ Brno, Dept Lab Methods, Fac Med, Brno, Czech Republic
关键词
chromogenic substrate assay; one-stage clotting assay; recombinant factor IX Fc fusion protein;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP-074 (16
引用
收藏
页码:87 / 87
页数:1
相关论文
共 50 条
  • [1] Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays
    Wilmot, H. V.
    Hogwood, J.
    Gray, E.
    HAEMOPHILIA, 2014, 20 (06) : 891 - 897
  • [2] EFANESOCTOCOG ALFA ACTIVITY ASSESSMENT WITH ONE-STAGE CLOTTING (OSA) AND CHROMOGENIC SUBSTRATE (CSA) FACTOR VIII ASSAYS
    Pipe, S.
    Sadeghi-Khomami, A.
    Konkle, B. A.
    Kitchen, S.
    Negrier, C.
    Liu, M.
    Santagostino, E.
    Willemze, A.
    Knobe, K.
    Chhabra, E. Seth
    HAEMOPHILIA, 2023, 29 : 32 - 32
  • [3] Performance of a recombinant fusion protein linking coagulation factor IX with recombinant albumin in one-stage clotting assays
    Horn, C.
    Negrier, C.
    Kalina, U.
    Seifert, W.
    Friedman, K. D.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (01) : 138 - 148
  • [4] Measurement of post-infusion recombinant factor IX activity by clotting and chromogenic assay
    Wilmot, H.
    Hogwood, J.
    Makris, M.
    Van Veen, J.
    Kitchen, S.
    Gray, E.
    HAEMOPHILIA, 2012, 18 : 105 - 105
  • [5] Pharmacokinetics of recombinant factor VIII (recombinate) using one-stage clotting and chromogenic factor VIII assay
    Lee, CA
    Owens, D
    Bray, G
    Giangrande, P
    Collins, P
    Hay, C
    Gomperts, E
    Schroth, P
    Barrowcliffe, T
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1644 - 1647
  • [6] Evaluation of Chromogenic Factor VIII Assay Compared with One-Stage Clotting Assay
    Akkaya, Emre
    Hatiboglu, Songul
    Koc, Basak
    Genc, Sema
    Unuvar, Aysegul
    Karaman, Serap
    Omer, Beyhan
    Karakas, Zeynep
    Zulfikar, Bulent
    CLINICAL LABORATORY, 2020, 66 (10) : 1937 - 1943
  • [7] Recombinant FIX Fc fusion protein activity assessment with the one-stage clotting assay: A multicenter, assessor-blinded, prospective study in Japan (J-Field Study)
    Fukutake, Katsuyuki
    Kobayashi, Tomomi
    Sommer, Jurg M.
    Hirakata, Toshiyuki
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2020, 42 (02) : 162 - 169
  • [8] IMPACT OF FIX ACTIVITY ASSAY RESULTS DETERMINED WITH ONE-STAGE CLOTTING AND CHROMOGENIC ASSAYS ON THE CLASSIFICATION OF HAEMOPHILIA B
    Pavic, J.
    Milos, M.
    Herak, Coen D.
    Juros, Fressl G.
    Boban, A.
    Bilic, E.
    Salek, Zupancic S.
    Zadro, R.
    HAEMOPHILIA, 2023, 29 : 20 - 20
  • [9] Clinical Implications of Discrepancy between One-Stage Clotting and Chromogenic Factor IX Activity in Hemophilia B
    Schmidt, David E.
    Truedsson, Asa
    Stralfors, Annelie
    Hojbjerg, Johanne Andersen
    Soutari, Nida
    Holmstrom, Margareta
    Ranta, Susanna
    Letelier, Anna
    Bowyer, Annette
    Ljung, Rolf
    Antovic, Jovan
    Bruzelius, Maria
    THROMBOSIS AND HAEMOSTASIS, 2024, 124 (01) : 32 - 39
  • [10] Potency assignment and measurement of recombinant FIX activity in human plasma-impact of aptt reagents on the one-stage clotting assay
    Gritsch, H.
    Romeder-Finger, S.
    Scheiflinger, F.
    Turecek, P. L.
    HAEMOPHILIA, 2014, 20 : 56 - 56